GRIMES & COMPANY, INC. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
GRIMES & COMPANY, INC. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$50,448
-9.0%
48,979
+2.5%
0.00%0.0%
Q2 2023$55,453
-2.6%
47,804
+26.8%
0.00%0.0%
Q1 2023$56,924
+44.5%
37,698
+139.2%
0.00%0.0%
Q4 2022$39,400
-41.2%
15,7600.0%0.00%
-33.3%
Q3 2022$67,000
+55.8%
15,760
+1.4%
0.00%
+50.0%
Q2 2022$43,000
-50.0%
15,536
+3.0%
0.00%
-50.0%
Q1 2022$86,000
-18.1%
15,088
+30.9%
0.00%
-20.0%
Q4 2021$105,000
-25.5%
11,527
-12.4%
0.01%
-16.7%
Q3 2021$141,000
-23.8%
13,152
+10.6%
0.01%
-25.0%
Q2 2021$185,00011,8900.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders